Navigation Links
Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
Date:11/25/2009

nada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. and in Canada. The Company also has a pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Except as required by law, the Company undertakes no obligation and does not intend to update these forward-looking statements.

SOURCE Labopharm Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Jose, California (PRWEB) September 22, 2014 ... Respiratory care market occupies a significant presence in ... the most widespread healthcare problems globally. Key factors ... unhealthy lifestyle habits such as smoking; increasing levels ... COPD; and expanding base of aging population vulnerable ...
(Date:9/22/2014)... September 22, 2014 The report ... Spain) aesthetic lasers and energy devices market revenue ... Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) ... also provides company shares by revenue for the ... Scope,     Information on market size ...
(Date:9/22/2014)... 2014 The Spa Standard, announced today ... the start-up in developing content and courses for their ... company over 15 years of experience in massage therapy, ... management with companies including Orient Express Hotels and the ... of educator, Jenny gained extensive industry insight through planning, ...
(Date:9/22/2014)... of modern medical development is medical imaging which ... monitoring, disease detection and treatments. The devices and ... without the use of image processing, pattern recognition, ... are areas of active research development which are ... the areas. A partial list of the important ...
(Date:9/22/2014)... MA, September 22, 2014 The American Association ... guidelines for the prevention and treatment of perioperative ... thoracic surgical procedures. The guidelines are published in ... . , "These guidelines have the potential to ... of patients who undergo lung surgery in the ...
Breaking Medicine News(10 mins):Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 3Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 4Health News:The Spa Standard Appoints Vice-President of Content and Course Development 2Health News:Researchers uncover the frontiers of R&D in medical imaging 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 3Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 4
... Doheny HealthDay Reporter , FRIDAY, Aug. 5 (HealthDay ... physically active, a new study finds that performance often trumps ... gained from about six months of exercise proved more satisfying ... the research. This suggest that with advancing years, a shift ...
... In summer, more dishes like gazpacho a cold soup containing ... new study has revealed that ingredients, vitamin C content as ... mixture, meaning that it should be eaten immediately after preparation., ... vitamin loss? A new study has examined gazpacho, one of ...
... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
... , THURSDAY, Aug. 4 (HealthDay News) -- People living ... the "Stroke Belt" are known to have significantly higher rates ... research reveals these residents are also at greater risk for ... "In 2010, we examined death rates from sepsis across ...
... discovery by scientists at Duke University Medical Center and ... effective combination of drug therapy to treat the second ... scientists have been looking for the primary cancer genes ... two chromosomes that held the probable mutations, but not ...
... 4 (HealthDay News) -- A map of the genetic mutations ... appears to reveal the biological cause of the tumors, researchers ... in seven samples of tissue from oligodendroglioma tumors, and concentrated ... previously associated with those types of tumors. The genes ...
Cached Medicine News:Health News:With Age, Focus on Body Shifts From Appearance to Function 2Health News:With Age, Focus on Body Shifts From Appearance to Function 3Health News:Gazpacho ingredients lose vitamin C during preparation 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:U.S. 'Stroke Belt' May Also Be 'Sepsis Belt' 2Health News:Elusive gene mutations found for malignant brain tumor 2Health News:Scientists May Have Found Missing Link to Common Brain Cancer 2
(Date:9/22/2014)... YORK , September 22, 2014 ... Market Report on "Global Market Study on Ophthalmic Devices: ... by 2020," the global ophthalmic devices market was valued at USD ... at a CAGR of 6.5% from 2014 to 2020, ... in 2020. Browse the full Global Market Study ...
(Date:9/22/2014)...  AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... machines, announced today that they are starting production of ... unit is designed for placement inside optical shops and ... statistics, there are over 20,000 optical stores in ... world,s first automated kiosk dedicated to cleaning and sanitizing ...
(Date:9/22/2014)... 2014  Neuralstem, Inc. (NYSE MKT: CUR) announced that ... Emory University, presented long-term follow up data on the ... in the treatment of amyotrophic lateral sclerosis (ALS or ... at the Annual Symposium on ALS of the Foundation ... Friday, and was not open to the public, covered ...
Breaking Medicine Technology:Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
... Oncimmune ® LLC , maker of EarlyCDT™-Lung , a ... and early detection of lung cancer , today announced ... International Conference May 13 - 18 in Denver will collectively ...  Oncimmune,s EarlyCDT-Lung test uses a panel of tumor ...
... (Polaris) today announced that the Company will highlight clinical ... ADI-PEG 20, during a symposium held on Tuesday, May ... Taiwan. Details about Polaris, upcoming pivotal Phase ... (HCC) will be presented by the principal investigator, Ghassan ...
Cached Medicine Technology:Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 2Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 3Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 4Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 5Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 2Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: